Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HER2/neu amplification and comedo type breast carcinoma.

Literature DB >> 2566812

HER2/neu amplification and comedo type breast carcinoma.

A Borg, F Linell, I Idvall, S Johansson, H Sigurdsson, M Fernö, D Killander.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 1989 PMID： 2566812 DOI： 10.1016/s0140-6736(89)92365-9

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors: R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal: Proc Natl Acad Sci U S A Date: 1992-11-01 Impact factor: 11.205

2. Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors: Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal: Breast Care (Basel) Date: 2010-08-23 Impact factor: 2.860

3. Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells.

Authors: Abbes Belkhiri; Altaf A Dar; Dun Fa Peng; Mohammad H Razvi; Cammie Rinehart; Carlos L Arteaga; Wael El-Rifai
Journal: Clin Cancer Res Date: 2008-06-25 Impact factor: 12.531

Review 4. Breast cancer and a proto-oncogene.

Authors: D M Barnes
Journal: BMJ Date: 1989-10-28

5. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.

Authors: D N Poller; M Galea; D Pearson; J Bell; W J Gullick; C W Elston; R W Blamey; I O Ellis
Journal: Breast Cancer Res Treat Date: 1991-12 Impact factor: 4.872

10. Correlation of c-erbB-2 protein expression with histologic grade, lymph node involvement and steroid receptor status in human breast tumors.

Authors: B Lampe; T Genz; V Maassen; S Mikorey; T Klosterhalfen
Journal: Arch Gynecol Obstet Date: 1992 Impact factor: 2.344

HER2/neu amplification and comedo type breast carcinoma.

1. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

2. Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

3. Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells.

Review 4. Breast cancer and a proto-oncogene.

5. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.

6. Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.

7. Transgenic oncogene mice. Tumor phenotype predicts genotype.

8. A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1.

9. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.

10. Correlation of c-erbB-2 protein expression with histologic grade, lymph node involvement and steroid receptor status in human breast tumors.